chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Arthritis, Condition aggravated, Fatigue, Infection
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 48 year old male pt who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt received injections of LYMErix on 5/23/00, 7/22/00, and 12/22/00 "according to the client." This represents a schedule of 0, 2 and 7 months rather than the recommended schedule of 0, 1 and 12 months. On 9/3/03, the pt's attorney alleged that the pt "suffered right arm pain, left shoulder pain, and right and left upper arms myalgias. The onset of his symptoms is not clear at this time." Upon follow-up received 1/12/04, the pt's attorney alleged that the pt 'received vaccinations in May 1999." The attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "fever, chills, joint pain, arthralgias, flu-like symptoms, fatigue, tingling in hands and feet." Additionally, the pt was alleged to have developed "complications of diabetes and neutropenia." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited his employment options and opportunities." According to the attorney, the pt was under the care of an infectious disease specialist and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 48.0
Sex: M
Vaccine: LYME
Symptoms: Influenza like illness, Leukopenia, Medication error, Myalgia, Pain
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 48 year old male pt who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt received injections of LYMErix on 5/23/00, 7/22/00, and 12/22/00 "according to the client." This represents a schedule of 0, 2 and 7 months rather than the recommended schedule of 0, 1 and 12 months. On 9/3/03, the pt's attorney alleged that the pt "suffered right arm pain, left shoulder pain, and right and left upper arms myalgias. The onset of his symptoms is not clear at this time." Upon follow-up received 1/12/04, the pt's attorney alleged that the pt 'received vaccinations in May 1999." The attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "fever, chills, joint pain, arthralgias, flu-like symptoms, fatigue, tingling in hands and feet." Additionally, the pt was alleged to have developed "complications of diabetes and neutropenia." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited his employment options and opportunities." According to the attorney, the pt was under the care of an infectious disease specialist and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 48.0
Sex: M
Vaccine: LYME
Symptoms: Paraesthesia
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 48 year old male pt who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt received injections of LYMErix on 5/23/00, 7/22/00, and 12/22/00 "according to the client." This represents a schedule of 0, 2 and 7 months rather than the recommended schedule of 0, 1 and 12 months. On 9/3/03, the pt's attorney alleged that the pt "suffered right arm pain, left shoulder pain, and right and left upper arms myalgias. The onset of his symptoms is not clear at this time." Upon follow-up received 1/12/04, the pt's attorney alleged that the pt 'received vaccinations in May 1999." The attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "fever, chills, joint pain, arthralgias, flu-like symptoms, fatigue, tingling in hands and feet." Additionally, the pt was alleged to have developed "complications of diabetes and neutropenia." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited his employment options and opportunities." According to the attorney, the pt was under the care of an infectious disease specialist and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 54.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Condition aggravated, Infection, Joint stiffness, Medication error
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 54 year old male pt who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt's medical history included neck pain and wrist pain. Concurrent medications were not reported. According to an office note on the date that the third dose of LYMErix was administered, the pt reported, "Neck pain worse. Wrist pain worse." The pt received injections of LYMErix on 10/11/00, 11/16/00, and 3/28/02 "according to the client." An office note from the vaccine provider indicated that the third dose of LYMErix (147F9) was administered on 2/28/02. Documentation from the vaccine provider was only supplied for the third vaccine dose. If the first two doses were administered as the pt reported, the vaccine was given on a 0, 1 and 16 months schedule rather than the recommended schedule of 0, 1 and 12 months. On 9/3/03, the pt's attorney alleged that the pt "suffered stiffness, urinary symptoms, multiple joint pain of wrists, thigh, ankle and neck." Time to onset from immunization, and outcomes of the alleged events were not reported. Upon follow-up received 1/12/04, the pt's attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "stiffness of the neck, multiple joint pains including bilateral hand and wrist pain, right thigh pain, and left ankle pain." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited his employment options and opportunities." According to the attorney, the pt was under the care of a rheumatologist, and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 54.0
Sex: M
Vaccine: LYME
Symptoms: Neck pain
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 54 year old male pt who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt's medical history included neck pain and wrist pain. Concurrent medications were not reported. According to an office note on the date that the third dose of LYMErix was administered, the pt reported, "Neck pain worse. Wrist pain worse." The pt received injections of LYMErix on 10/11/00, 11/16/00, and 3/28/02 "according to the client." An office note from the vaccine provider indicated that the third dose of LYMErix (147F9) was administered on 2/28/02. Documentation from the vaccine provider was only supplied for the third vaccine dose. If the first two doses were administered as the pt reported, the vaccine was given on a 0, 1 and 16 months schedule rather than the recommended schedule of 0, 1 and 12 months. On 9/3/03, the pt's attorney alleged that the pt "suffered stiffness, urinary symptoms, multiple joint pain of wrists, thigh, ankle and neck." Time to onset from immunization, and outcomes of the alleged events were not reported. Upon follow-up received 1/12/04, the pt's attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "stiffness of the neck, multiple joint pains including bilateral hand and wrist pain, right thigh pain, and left ankle pain." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited his employment options and opportunities." According to the attorney, the pt was under the care of a rheumatologist, and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 39.0
Sex: F
Vaccine: LYME
Symptoms: Arthralgia, Arthritis, Cough, Fatigue, Hypoglycaemia
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 40 year old female pt who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received as part of litigation proceedings. The pt's medical history included joint pain. Concurrent conditions and medications were not reported. The pt  received injections of LYMErix on 7/23/99, on 9/2/99 and 10/31/00 "according to the client." Confirmation from the vaccine provider was supplied for only the 7/23/99 dose. Upon follow-up received 1/12/04, the pt's attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "joint pain in her hips, knees and ankles and severe fatigue." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited her employment options and opportunities." According to the attorney, the pt was under the care of a rheumatologist, and received anti-inflammatory and other medications without relief of symptoms. On 9/3/03, the pt's attorney alleged that the pt "suffered joint pain, which was more severe and longer lasting beginning 10/17/00 according to the client." Treatment and outcome of the alleged event was not reported. The following info was provided via the pt's medical records, which did not confirm vaccination dates nor provide additional info regarding reported adverse events. Medical history included knee injury, congenital hip dysplasia, and Lyme disease. Following the reported onset of exacerbation of joint pain, the pt experienced left flank lipoma, cough, sinusitis, and hypoglycemia. These were not reported as adverse events due to vaccine administration, but were found during the course of review of the pt's medical records. Therefore, they are not listed as adverse events. On 15Sept04, the pt's attorney alleged that the pt experienced pronounced joint pain of the hips, knees, and ankles, fatigue, short term memory loss, poor concentration, gait disturbance, and a loss of stamina. Time to onset, treatment, and outcome were not reported. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 39.0
Sex: F
Vaccine: LYME
Symptoms: Infection, Sinusitis
Clinical narrative: This report described the occurrence of Lyme arthritis and/or Lyme disease in a 40 year old female pt who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received as part of litigation proceedings. The pt's medical history included joint pain. Concurrent conditions and medications were not reported. The pt  received injections of LYMErix on 7/23/99, on 9/2/99 and 10/31/00 "according to the client." Confirmation from the vaccine provider was supplied for only the 7/23/99 dose. Upon follow-up received 1/12/04, the pt's attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "joint pain in her hips, knees and ankles and severe fatigue." The attorney further alleged that the pt suffered pain that was described as "debilitating at times" and which "severely limited her employment options and opportunities." According to the attorney, the pt was under the care of a rheumatologist, and received anti-inflammatory and other medications without relief of symptoms. On 9/3/03, the pt's attorney alleged that the pt "suffered joint pain, which was more severe and longer lasting beginning 10/17/00 according to the client." Treatment and outcome of the alleged event was not reported. The following info was provided via the pt's medical records, which did not confirm vaccination dates nor provide additional info regarding reported adverse events. Medical history included knee injury, congenital hip dysplasia, and Lyme disease. Following the reported onset of exacerbation of joint pain, the pt experienced left flank lipoma, cough, sinusitis, and hypoglycemia. These were not reported as adverse events due to vaccine administration, but were found during the course of review of the pt's medical records. Therefore, they are not listed as adverse events. On 15Sept04, the pt's attorney alleged that the pt experienced pronounced joint pain of the hips, knees, and ankles, fatigue, short term memory loss, poor concentration, gait disturbance, and a loss of stamina. Time to onset, treatment, and outcome were not reported. Information from Annual Follow-up report states this adverse event was received through the litigation process. Additional information regarding the event, including outcome information, is being pursued through the litigation process and will be reported if obtained.
Age: 41.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain, Anaphylactic reaction, Asthenia, Dizziness, Dyspnoea
Clinical narrative: Symptoms of anaphylaxis: tingling/swelling of lips and tongue, dizziness, weakness, itching, constriction of smooth muscles beginning at throat continuing downward and through urethra, leg and stomach cramps, rapid heart rate, difficulty in breathing.
Age: 41.0
Sex: F
Vaccine: HEP
Symptoms: Face oedema, Heart rate increased, Muscle spasms, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: Symptoms of anaphylaxis: tingling/swelling of lips and tongue, dizziness, weakness, itching, constriction of smooth muscles beginning at throat continuing downward and through urethra, leg and stomach cramps, rapid heart rate, difficulty in breathing.
Age: 41.0
Sex: F
Vaccine: HEP
Symptoms: Pruritus, Tongue oedema
Clinical narrative: Symptoms of anaphylaxis: tingling/swelling of lips and tongue, dizziness, weakness, itching, constriction of smooth muscles beginning at throat continuing downward and through urethra, leg and stomach cramps, rapid heart rate, difficulty in breathing.
Age: 14.0
Sex: M
Vaccine: TD
Symptoms: Anaphylactic shock, Hypersensitivity
Clinical narrative: 11:03 Td given IM L deltoid; allergic reaction (anaphylactic shock). 11:05 50mg Benadryl PO. 11:10 EMS notified. 11:12 0.3 epi given L thigh. Pt was not seen in ER or doctor's office. Once EMS arrived at the school and established the patient's recovery, they did not feel it was necessary to transport him. Therefore no medical records.
Age: 0.4
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Agitation, Encephalitis, Musculoskeletal stiffness
Clinical narrative: Grandmother called to report child was seen at clinic on 12/8/03 due to "child crying all the time" since early AM. Reports going to ER at hospital at 8pm due to "stiffens up and cries all the time." Was hospitalized from 12/8/03 thru 12/24/03. Grandmother reports encephalitis.
Age: 56.0
Sex: M
Vaccine: SMALL
Symptoms: Cardiomyopathy
Clinical narrative: Dilated cardiomyopathy. Began having symptoms approx 2 months after smallpox vaccine. Following up with cardiologist records requested. 60 day follow up 4/5/04: Diagnosed with dilated cardiomopathy. Patient reports cardiac output still less than normal. Patient continues to follow up with cardiologist. Per annual follow up report, Still taking med for A fibrillation, Cardiac output returned to normal, still a few episodes of PSVT.
Age: 58.0
Sex: F
Vaccine: HEPAB
Symptoms: Anxiety, Dizziness, Fatigue, Headache, Neuropathy
Clinical narrative: After second shot: unsteadiness, tingling sensation in fingers 3 weeks after shot. After third shot: optic neuritis, 4 days after shot. Blind spot in eye. The medical records received on 1/28/04 states clouding vision, fatigue, headache, ischemic neuroopathy and anxiety. The medical record received on 2/24/04 states visual acuity diminished and visual field defect.   Follow up on 07/28/04 states: "Pt has not recovered from adverse events. There is a permanent partial loss of vision in one eye. I believe the symptoms began after the second shot: dizziness, tingling in fingers, fierce headaches in temples, fatigue, sensitivity to light." As per annual follow report permanent blindness in portion of left eye.
Age: 58.0
Sex: F
Vaccine: HEPAB
Symptoms: Optic neuritis, Paraesthesia, Photophobia, Visual disturbance
Clinical narrative: After second shot: unsteadiness, tingling sensation in fingers 3 weeks after shot. After third shot: optic neuritis, 4 days after shot. Blind spot in eye. The medical records received on 1/28/04 states clouding vision, fatigue, headache, ischemic neuroopathy and anxiety. The medical record received on 2/24/04 states visual acuity diminished and visual field defect.   Follow up on 07/28/04 states: "Pt has not recovered from adverse events. There is a permanent partial loss of vision in one eye. I believe the symptoms began after the second shot: dizziness, tingling in fingers, fierce headaches in temples, fatigue, sensitivity to light." As per annual follow report permanent blindness in portion of left eye.
Age: 1.7
Sex: M
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Acute respiratory distress syndrome, Apnoea, Azotaemia, Bacterial infection, Pneumonia
Clinical narrative: Possible vaccine failure. Onset 12/9/03. Pt has pneumonia and sepsis. Hospitalized since 12/15/03. Pt on dialysis and ventilator. Will be hospitalized indefinitely. I have been calling hospital for weekly updates. Follow up on 2/3/03 per phone report: Call from CDC Strep lab. The serotype for this child's specimen was 19A, which is not covered by Prevnar.  The medical records received on 2/4/04 state septic shock, adult respiratory distress syndrome, hemolytic uremic syndrome, pulmonary edema, and respiratory failure.  60-day follow up on 04/19/04: "Pt has recovered from adverse events.  Hospitalized for 45 days, subtype 19A (not in PCV-7)."
Age: 1.7
Sex: M
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Pulmonary oedema, Sepsis, Shock, Viral infection
Clinical narrative: Possible vaccine failure. Onset 12/9/03. Pt has pneumonia and sepsis. Hospitalized since 12/15/03. Pt on dialysis and ventilator. Will be hospitalized indefinitely. I have been calling hospital for weekly updates. Follow up on 2/3/03 per phone report: Call from CDC Strep lab. The serotype for this child's specimen was 19A, which is not covered by Prevnar.  The medical records received on 2/4/04 state septic shock, adult respiratory distress syndrome, hemolytic uremic syndrome, pulmonary edema, and respiratory failure.  60-day follow up on 04/19/04: "Pt has recovered from adverse events.  Hospitalized for 45 days, subtype 19A (not in PCV-7)."
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Hypokinesia, Nausea, Pain, Shoulder pain
Clinical narrative: Pt complained of flu shot given to high in left arm.  After leaving flu clinic, severe pain began with inability to move arm or use fingers also felt nauseated with pain.  Currently still having left shoulder pain, limiting use of left arm.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Bronchitis, Cough, Nasal congestion, Pain, Pyrexia
Clinical narrative: 12/19/03: Friday at approximately 7pm, pt exhibited congestion, cough, fever-temperature unknown, and body aches, relieved with children's Motrin for cold, then intermittent relieved by more children's Motrin.  He's improving, but his fever is up and down.  Flu shot given Friday at 15:30.  Still febrile, recovering.
Age: 1.3
Sex: F
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Cough, Grand mal convulsion, Irritability, Pyrexia, Rhinorrhoea
Clinical narrative: Fever, seizure (grand mal) 01/16/04.  Shots 01/12/04 (DTAP, IPV, MMR, FluZone).  Nurse follow up on 06/18/04 states: "ADD: cough, runny nose, fussy, screaming."
Age: 2.1
Sex: M
Vaccine: FLU3
Symptoms: Blister, Erythema, Urticaria
Clinical narrative: Received 1st dose ever of flu vaccine on Tuesday 12/16/03 09:30.  Mom noticed hives, Wednesday AM 07:30 12/17/03 on torso only.  Looked reddish in color with blister like center.  But fades to nothing.  When pt gets warm, hives come out again by Friday, hives appearing on hands, face and legs also.  Called PMD, was told not a reaction to flu vaccine.  Could give Benadryl.  Did give Benadryl every 6-8 hours since then.  As of 12/23/03 PM, still had a few hives outbreak with cool bath this AM.
Age: 39.0
Sex: M
Vaccine: FLU3, HEPA, MMR, TYP
Symptoms: Oedema, Sensation of pressure
Clinical narrative: Had shots last Thursday, now today his jaw is swollen.  Both sides are affected and also forehead pressure symptoms started today.  Noticeable edema not painful.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Paraesthesia, Pruritus, Rash, Skin burning sensation
Clinical narrative: Seen in employee health 12/12/03: states took flu 12/10 achy 12/11, took Motrin "off and on" 12/12.  Started "itching" upper extremities and back.  Noticed rash on neck and upper back. Complained of burning, tingling and itching.  No respiratory distress, took Benadryl 25mg per mouth earlier.  Exam-slight rash noted at deltoid region.  Red rash noted upper back.  12/15/03: Reports resolved 12/13/03 PM.
Age: 24.0
Sex: F
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 23.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 31.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 20.0
Sex: F
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 32.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 34.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 26.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Maculr papular truncal rash.
Age: 18.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash.
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Rash maculo-papular
Clinical narrative: Macular papular truncal rash about 11 days after smallpox vaccine.
Age: 43.0
Sex: F
Vaccine: TD
Symptoms: Chest discomfort, Dizziness
Clinical narrative: Dizziness, tightness in chest approximately 40 minutes after vaccine administered. Advised by PCP to take Benadryl.
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Injection site vesicles, Rash
Clinical narrative: 2 weeks after receiving varicella developed (1) blister area on chin and (1) at injection site also fine rash on chest and back.  No fever.
Sex: F
Vaccine: MMR
Symptoms: Headache, Hyperaesthesia, Myalgia, Rash
Clinical narrative: Developed HA, muscle aches, skin sensitivity 1/18/04. Rash 1/19/04.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Crying, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Child crying for 2 hours, right leg swollen, red and tender. Brought to office; tender right thigh around area of injection site, 2" in diameter, swollen and hot.
Age: 40.0
Sex: F
Vaccine: MMR, TD
Symptoms: Injection site mass, Injection site pain
Clinical narrative: 9/10/03 Received MMR, Td in left deltoid . Shot was painful and site remained with pain for 1 week and tender for 2 months. The site also had a pea sized lump for 2 months and a pea size lump is still present. Patient complained of intermittent pain at injection site that radiates down approximately 3-4 inches and can be relieved with massage.
Age: 45.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Blood pressure increased, Fatigue, Pruritus, Rash, Swelling
Clinical narrative: Client exposed to chicken pox on 10/19/03. Requested and received Varivax on 10/20/03. 11/12/03 to PMD for rash; red, quarter size swelling with white center on finger, 3 on lower back, 2-3 on thigh, 1 on leg, head itching, fatigue. BP elevated; no fever.
Age: 45.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Blood pressure increased, Erythema, Fatigue, Infection, Oedema
Clinical narrative: Client exposed to chicken pox on 10/19/03. Requested and received Varivax on 10/20/03. 11/12/03 to PMD for rash; red, quarter size swelling with white center on finger, 3 on lower back, 2-3 on thigh, 1 on leg, head itching, fatigue. BP elevated; no fever.
Age: 45.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Pruritus, Rash
Clinical narrative: Client exposed to chicken pox on 10/19/03. Requested and received Varivax on 10/20/03. 11/12/03 to PMD for rash; red, quarter size swelling with white center on finger, 3 on lower back, 2-3 on thigh, 1 on leg, head itching, fatigue. BP elevated; no fever.
Age: 80.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt called on 12/16/03. Redness. Warmth and tenderness to site of injection. This was a revaccination due to cold in relief. Last injection was 7/7/03.
Age: 62.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Swelling, redness from shoulder to elbow. Patient received pneumococcal on 5/27/03 but vaccine was stored too cold.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Red, swollen deltoid area.  Recall vaccine due to cold refrigerator temperature on 01/24/03.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Urticaria
Clinical narrative: Within minutes after receiving Varivax pt had hives distal to the site of administration.
Sex: M
Vaccine: DTAP
Symptoms: Injection site pain, Rash
Clinical narrative: Rash at injection site-3 days after injection (reported 12/19/03).  Complained of tenderness at site, mild symptoms still resolving.
Age: 0.4
Sex: M
Vaccine: DTPHIB
Symptoms: Agitation, Crying
Clinical narrative: I gave him Tylenol at time of vaccination 4 hours later he was crying unconsolably for approximately one hour.  I gave more ibuprofen and it helped.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Nerve injury
Clinical narrative: Acute VI nerve palsy-onset 01/03/2004.
Age: 0.7
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: Pt had fever of 105 F and trouble breathing.
Age: 2.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Feeling hot
Clinical narrative: 1 7/8 x 1.5 cm area redness/warmth.  No purulence.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Skin ulcer
Clinical narrative: Multiple lesions, slightly itchy, some crusted over.
Age: 3.0
Sex: F
Vaccine: MEA
Symptoms: Antisocial behaviour, Aphasia, Autism, Cognitive disorder, Diarrhoea
Clinical narrative: Following the measles vaccine, pt had multiple low grade fevers, chronic diarrhea, dilated pupils, sweaty palms and within 2 months lost all of her speech, eye contact, social skills and all play skills.  She has been diagnosed with autism and today at 4 years she was no speech and is cognitively impaired.  Also prior to measles we suspect she received excessive levels of mercury from thimerosal in vaccines.
Age: 3.0
Sex: F
Vaccine: MEA
Symptoms: Hyperhidrosis, Laboratory test abnormal, Mydriasis, Neurological symptom, Pyrexia
Clinical narrative: Following the measles vaccine, pt had multiple low grade fevers, chronic diarrhea, dilated pupils, sweaty palms and within 2 months lost all of her speech, eye contact, social skills and all play skills.  She has been diagnosed with autism and today at 4 years she was no speech and is cognitively impaired.  Also prior to measles we suspect she received excessive levels of mercury from thimerosal in vaccines.
Age: 48.0
Sex: F
Vaccine: TD
Symptoms: Feeling hot, Oedema peripheral, Skin nodule
Clinical narrative: Rec'd tetanus immun. 1/12/04. Large lump and swelling, red, warm to touch 2 1/2 by 3 1/2cm swelling going down arm to elbow.
Age: 2.5
Sex: M
Vaccine: PNC
Symptoms: Cellulitis, Erythema, Injection site mass, Injection site warmth
Clinical narrative: C/O "red, hard and hot with redness travelling down to thigh and knee." Instructed mom to see MD-diagnosed with cellulitis and po abx given (Keflex). No response so on 1/1 MD prescribed Bactrem and resolved without further complications.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Hypokinesia, Injection site erythema, Injection site pain, Nausea
Clinical narrative: Left upper arm red and painful, starting about 6 hours after injection with difficulty raising the arm which lasted about 1 day.  She was also nauseated and chills which lasted about 10 hours the first night.  Had frequent voiding during the 1st night.  No treatment.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Pollakiuria
Clinical narrative: Left upper arm red and painful, starting about 6 hours after injection with difficulty raising the arm which lasted about 1 day.  She was also nauseated and chills which lasted about 10 hours the first night.  Had frequent voiding during the 1st night.  No treatment.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Herpes zoster, Skin ulcer, Viral infection
Clinical narrative: Herpes zoster left leg; fear lesion back, culture negative.  Culture panel lesion (+) staph series.
Age: 7.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Pt received varicella vaccine 09/12/2002.  Pt diagnosed with chickenpox today in office 01/15/2004.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Redness, swelling of left deltoid.  Pt received Pneumovax on 06/23/03 that was stored to cold.
Age: 13.0
Sex: M
Vaccine: HEP, PPV, TD
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Redness, swelling of site.  Pt received Pneumovax 05/13/03 that was stored below 35 degrees F.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema
Clinical narrative: Swelling, redness.  Pt had last Pneumovax on 06/02/03, vial was stored too cold.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dysphonia, Laboratory test abnormal, Pneumonia, Pyrexia
Clinical narrative: Within 4 hours of vaccine fever 102 degrees, chills, voice hoarse, incentive spisometry 2500 prevaccine, decreased 1500-on 01/06/04.
Age: 25.0
Sex: M
Vaccine: DT
Symptoms: Asthenia, Body temperature decreased, Disturbance in attention, Dizziness, Dyspnoea
Clinical narrative: Myalgias, fatigue, weakness, esposidic paralysis in arm and leg muscles, deep muscular heat, deep muscular pain in back, neck, legs, arms and chest; no endurance; dizziness; labor breathing; headache; low temperature: 95-97F; muscle aches; muscle cramps; difficulty with words and concentration; difficulty getting up stairs and up out of chairs; body weakness; malaise. Follow up 4/13/04: Last Wednesday, 4/7/04, doctor concluded that patient had chronic hepatitis (did not specify type) as a result of vaccine received on 11/13/03. Mentioned that it was not communicable. Blood test in March showe liver enzymes were elevated just like in December.
Age: 25.0
Sex: M
Vaccine: DT
Symptoms: Fatigue, Headache, Malaise, Muscle spasms, Muscular weakness
Clinical narrative: Myalgias, fatigue, weakness, esposidic paralysis in arm and leg muscles, deep muscular heat, deep muscular pain in back, neck, legs, arms and chest; no endurance; dizziness; labor breathing; headache; low temperature: 95-97F; muscle aches; muscle cramps; difficulty with words and concentration; difficulty getting up stairs and up out of chairs; body weakness; malaise. Follow up 4/13/04: Last Wednesday, 4/7/04, doctor concluded that patient had chronic hepatitis (did not specify type) as a result of vaccine received on 11/13/03. Mentioned that it was not communicable. Blood test in March showe liver enzymes were elevated just like in December.
Age: 25.0
Sex: M
Vaccine: DT
Symptoms: Myalgia, Pain, Pyrexia, Spastic paralysis, Speech disorder
Clinical narrative: Myalgias, fatigue, weakness, esposidic paralysis in arm and leg muscles, deep muscular heat, deep muscular pain in back, neck, legs, arms and chest; no endurance; dizziness; labor breathing; headache; low temperature: 95-97F; muscle aches; muscle cramps; difficulty with words and concentration; difficulty getting up stairs and up out of chairs; body weakness; malaise. Follow up 4/13/04: Last Wednesday, 4/7/04, doctor concluded that patient had chronic hepatitis (did not specify type) as a result of vaccine received on 11/13/03. Mentioned that it was not communicable. Blood test in March showe liver enzymes were elevated just like in December.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: 7x7cm area of erythema right arm where DPT given warm and red-not infected.
Age: 44.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Pyrexia
Clinical narrative: Pt was given Pneumovax 0.5cc IM right deltoid.  Within 24 hours, developed redness and gross swelling at injection site with fever 100 degrees.  Ice applied. Consecutive treatment and observation.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Redness, swelling, warm tight feeling and hard. Arm feels warm.
Age: 45.0
Sex: F
Vaccine: HEP
Symptoms: Discomfort, Hypokinesia, Musculoskeletal stiffness, Pain
Clinical narrative: Two days after injection, noticed palm and stiffness radiating to shoulder and neck on left arm.  Complained of limited movement to arm-unable to lift arm above head or reach back without pain.  Discomfort noticed above elbow.  Report hand pain.  Strength and grip normal.
Age: 2.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Cellulitis
Clinical narrative: Given Pediarix on left thigh cellulitis-needed antibiotic treatment.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, IPV, MMR, VARCEL
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure;
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Oedema peripheral
Clinical narrative: 01/12/2004 @ 14:11: Mom calling describing large amount of swelling, redness to right arm from shoulder to elbow.  Started 24 hours after shot.  Given et cont today although better today. Encouraged use of Motrin/Advil every 6 hours as needed.
Age: 64.0
Sex: M
Vaccine: TD
Symptoms: Injection site haemorrhage, Injection site oedema
Clinical narrative: Pt complained of swelling/ecchymosis from axilla over past antecubital.  No edema/ecchymosis bicep noted deltoid muscle.  Pt states 5 days prior he heard something pop in left deltoid but had no injury until after tetanus shot.
Age: 0.2
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV
Symptoms: Rash
Clinical narrative: It was reported that a two month old male pt received ActHIB, IPOL, and Tripedia on 4/22/03. The pt had also received hep B vaccine. On 4/24/03, the pt developed a rash on face and both legs. It was reported that the pt recovered from this event.
Age: 0.5
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Screaming
Clinical narrative: From initial information received on 05/23/03 from a physician regarding an adverse event occurring in the USA, it was reported that a six-month old male pt received ActHIB, Lot # UA839AA, Tripedia, Lot # U0856BA, and Prevnar, Lot # 492-393 (manufactured by Wyeth), on 05/16/03 at 11:00AM.  Routes and sites of administration were not reported.  Later that day, the pt started crying and continued until 11:00 PM that night.  On 05/17/03, the pt's mother called the physician.  Tylenol was recommended. The crying had stopped.  On 05/19/03, the mother called the physician to say that the baby seemed tired, but was doing much better.  The pt reportedly recovered from these events.  The reporter of this case is the same reporter of case 2003-01026.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: From initial correspondence received at AP Inc on 11/21/2002, from manufacturer (reference number A0378256A), it was reported that a 3 year old male child received 0.5ml dosage of Tripedia, Lot # U0581AA, in the right leg on 08/14/02.  Nurse thinks the dose number in series is #5.  Pt experienced large areas of erythema and a warm, swollen patch around the injection site (2x3 inches).  Onset date is unknown. The site of the erythema was not reported. The pt recovered.
Age: 5.0
Sex: U
Vaccine: DTAP
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: From telephone correspondence received at AP Inc on 12/11/02, it was reported that a 5 year old child received Tripedia (Lot # U0581AA) given in the left deltoid in August of 2002.  One to two days after vaccination, the pt developed swelling 3x size of arm.  The area was red, warm and painful.  It was diagnosed by the physician as Cellulitis.  No lab/diagnostic tests were needed, it was very obvious.  The pt was not taking any other medication at time of vaccination, and did not receive any other vaccinations within a 4 week time period.  The pt did not have any illnesses or pre-existing diagnoses at time of vaccination.  The pt reportedly recovered from the event.  The case is closed.  See cases U2002-00494, U2002-01160, U2002-01161 and U2002-01163 with the same reporter.
Age: 5.0
Sex: U
Vaccine: DTAP
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: From telephone correspondence received at manufactuer on 12/11/02, it was reported that a 5 year old child received Tripedia (Lot # U0581AA) given in the left deltoid in August of 2002.  On to two days after vaccination, the pt developed swelling 3x size of arm.  The area was red, warm and painful.  It was diagnosed by the physician as Cellulitis.  No lab/diagnostic tests were needed, as it was very obvious.  The pt was not taking any other medication at time of vaccination, did not receive any other vaccinations within a 4 week time period, and did not have any illnesses or pre-existing diagnoses at time of vaccination.  The pt reportedly recovered from this event. The case is closed.  See cases U2002-00494, U2002-01159, U2002-01161 and U2002-01163 with same reporter.
Age: 5.0
Sex: U
Vaccine: DTAP
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: From telephone correspondence received at manufacturer on 12/11/02, it was reported that a 5 year old child received Tripedia (Lot # U0581AA) given in the left deltoid in August of 2002.  One to two days after vaccination, the pt developed swelling 3x size of arm. The area was red, warm and painful. It was diagnosed by the physician as Cellulitis.  No lab/diagnostic tests were needed, as it was very obvious.  The pt was not taking any other medication at time of vaccination, did not receive any other vaccinations within a 4 week time period, and did not have any illnesses or pre-existing diagnoses at time of vaccination.  The pt reportedly recovered from this event.  The case is closed.  See cases U2002-00494, U2002-01159, U2002-01160, U2002-001162 & U2002-01163 with same reporter.
Age: 5.0
Sex: U
Vaccine: DTAP
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site warmth
Clinical narrative: From telephone correspondence received at manufacturer on 12/11/02, it was reported that a 5 year old child received Tripedia (Lot # U0581AA) given in the left deltoid in August of 2002. One to two days after vaccination, the pt developed swelling 3x size of arm. The area was red, warm and painful.  It was diagnosed by the physician as Cellulitis. No lab/diagnostic tests were needed, as it  was very obvious.  The pt was not taking any other medications at time of vaccination, did not receive any other vaccinations within a 4 week time period and did not have any illnesses or pre-existing diagnoses at time of vaccination.  The pt reportedly recovered from this event.  The case is closed.  See cases U2002-00494, U2002-01159, U2002-01161 & U2002-01162 with same reporter.
Age: 0.9
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Injection site induration
Clinical narrative: From telephone contact received at manufacturer on 01/06/03, it was reported that a 9 month old male received Tripedia (Lot # U0581AA) on 09/16/02.  Within 72 hours after vaccination, the pt developed red spots and hard at the injection site. After 7 - 10 days it developed into a large red spot, size of half dollar (reported by parent, also states she reported to VAERS).  It is unknown if the pt recovered.
Age: 46.0
Sex: M
Vaccine: HEPA, YF
Symptoms: Abdominal pain, Chills, Diarrhoea, Pyrexia
Clinical narrative: temp of 102/ abd pain,chills.diarrhea starting 5 days after injection and lasted 3 day
Age: 65.0
Sex: F
Vaccine: TD
Symptoms: Injection site hypersensitivity, Injection site warmth, Oedema peripheral, Pain, Pruritus
Clinical narrative: PATIENT BEGAN TO HAVE A SORE ARM THE EVENING THAT THE VACCINE WAS GIVEN. THE NEXT DAY SHE FELT SORE ALL OVER AND BEGAN TO RUN A LOW GRADE TEMP (STATED THAT SHE DID NOT ACTUALLY TAKE HER TEMP).  THE DELTOID AREA OF HER RIGHT ARM BEGAN TO SWELL AND WAS HOT TO THE TOUCH.  SKIN TIGHT ON THE AFFECTED ARM.  ARM BEGAN TO ITCH 5 DAYS LATER.  ALL OTHER SYMPTOMS HAVE RESIDED EXCEPT FOR MILD SWELLING, ITCHING AT INJECTION SITE, AND MINIMAL SORENESS IN DELTOID AREA.
Age: 65.0
Sex: F
Vaccine: TD
Symptoms: Pyrexia
Clinical narrative: PATIENT BEGAN TO HAVE A SORE ARM THE EVENING THAT THE VACCINE WAS GIVEN. THE NEXT DAY SHE FELT SORE ALL OVER AND BEGAN TO RUN A LOW GRADE TEMP (STATED THAT SHE DID NOT ACTUALLY TAKE HER TEMP).  THE DELTOID AREA OF HER RIGHT ARM BEGAN TO SWELL AND WAS HOT TO THE TOUCH.  SKIN TIGHT ON THE AFFECTED ARM.  ARM BEGAN TO ITCH 5 DAYS LATER.  ALL OTHER SYMPTOMS HAVE RESIDED EXCEPT FOR MILD SWELLING, ITCHING AT INJECTION SITE, AND MINIMAL SORENESS IN DELTOID AREA.
Age: 1.6
Sex: M
Vaccine: DT, PNC
Symptoms: Apnoea, Crying, Musculoskeletal stiffness, Pyrexia, Staring
Clinical narrative: Arrived in emergency Department with rectal temp of 104.2.  Parents reported patient seen to stop breathing in car.  Appearred rigid and to be staring at the ceiling.  Father performed CPR briefly.  On arrival patient was crying lustily.
Age: 44.0
Sex: M
Vaccine: YF, YF
Symptoms: Chills, Cough, Myalgia, Pyrexia
Clinical narrative: General muscle aches, chills with low grade fever, cough.
Age: 44.0
Sex: M
Vaccine: YF, YF
Symptoms: Cough, Fatigue, Influenza like illness, Pain, Pyrexia
Clinical narrative: General muscle aches, chills with low grade fever, cough.
Age: 37.0
Sex: F
Vaccine: ANTH
Symptoms: Menorrhagia
Clinical narrative: EXPERIENCED UNUSUAL HEAVY BLEEDING.  NOT DURING MENSTRAL CYCLE TIME BUT RIGHT BEFORE.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Disorientation, Dizziness, Dyspnoea, Fatigue
Clinical narrative: From initial correspondence received via fax on 10/18/02, it was reported that a 26 year old female patient was vaccinated with Fluzone on 10/14/02 IM in the left deltoid. The patient reported awakening from a sound sleep at 11:30PM on 10/14/02 and being unable to breathe. This was followed by an episode of coughing, shakiness, dizziness, disorientation, blurred vision, and later vomiting. She believes this might be related to Fluzone influenza vaccine received almost 12 hours earlier. The patient denies fever, rash, facial or upper airway swelling, abdominal pain/cramping, or diarrhea. There has been no recent illness among family members, or variation in food consumed by them as a group. At present, patient describes feeling worn out, but denies any respiratory distress. The responsible physician's assessment states, evolving sensitization versus delayed hypersensitivity response to unknown substance. Whereas serious adverse reaction to vaccines can produce similar respiratory symptoms, a delay of almost 12 hours seems unlikely. I am more likely to suspect the possibility of individual or synergistic response to one or both recently introduced Clarinex and Vitamin/Herbal Stimulant, the former of which is an unregulated product containing quite a number of plant products of undetermined concentration. It is noted that no ephedrine content is noted. The employee is advised to contact her PCP today to discuss any change in her current medical/supplement regimen, and guidance regarding the advisability of future vaccination.